Downmodulation of bFGF-binding protein expression following restoration of p53 function (Q38295193)

1 September 2017

title

Downmodulation of bFGF-binding protein expression following restoration of p53 function (English)

1 reference

1 September 2017

Sherif ZA

1

1 reference

1 September 2017

Nakai S

2

1 reference

1 September 2017

Pirollo KF

3

1 reference

1 September 2017

Rait A

4

1 reference

1 September 2017

Chang EH

5

1 reference

1 September 2017

publication date

1 October 2001

1 reference

1 September 2017

1 reference

1 September 2017

volume

8

1 reference

1 September 2017

issue

10

1 reference

1 September 2017

page(s)

771-782

1 reference

What Is the Evidence That Tumors Are Angiogenesis Dependent?

1 September 2017

cites work

1 reference

https://api.crossref.org/works/10.1038%2FSJ.CGT.7700361

7 January 2021

Growth factors in angiogenesis: current interest and therapeutic potential

1 reference

https://api.crossref.org/works/10.1038%2FSJ.CGT.7700361

7 January 2021

Gene transfer of IFN-gamma into established brain tumors represses growth by antiangiogenesis.

1 reference

https://api.crossref.org/works/10.1038%2FSJ.CGT.7700361

7 January 2021

Antiangiogenic gene therapy for cancer via systemic administration of adenoviral vectors expressing secretable endostatin

1 reference

https://api.crossref.org/works/10.1038%2FSJ.CGT.7700361

7 January 2021

Development of angiogenesis inhibitors for cancer therapy

1 reference

https://api.crossref.org/works/10.1038%2FSJ.CGT.7700361

7 January 2021

The transforming growth factor-beta signaling pathway in tumorigenesis.

1 reference

https://api.crossref.org/works/10.1038%2FSJ.CGT.7700361

7 January 2021

Mechanisms of angiogenesis and their use in the inhibition of tumor growth and metastasis.

1 reference

https://api.crossref.org/works/10.1038%2FSJ.CGT.7700361

7 January 2021

Vascular endothelial growth factor receptors in the regulation of angiogenesis and lymphangiogenesis

1 reference

https://api.crossref.org/works/10.1038%2FSJ.CGT.7700361

7 January 2021

The heparin-binding (fibroblast) growth factor family of proteins

1 reference

https://api.crossref.org/works/10.1038%2FSJ.CGT.7700361

7 January 2021

Molecular cloning of a novel cytokine cDNA encoding the ninth member of the fibroblast growth factor family, which has a unique secretion property

1 reference

https://api.crossref.org/works/10.1038%2FSJ.CGT.7700361

7 January 2021

Structure and expression of the rat mRNA encoding a novel member of the fibroblast growth factor family

1 reference

https://api.crossref.org/works/10.1038%2FSJ.CGT.7700361

7 January 2021

Human tumor cells synthesize an endothelial cell growth factor that is structurally related to basic fibroblast growth factor

1 reference

https://api.crossref.org/works/10.1038%2FSJ.CGT.7700361

7 January 2021

Both normal and tumor cells produce basic fibroblast growth factor

1 reference

https://api.crossref.org/works/10.1038%2FSJ.CGT.7700361

7 January 2021

Basic fibroblast growth factor as a growth inhibitor for cultured human tumor cells

1 reference

https://api.crossref.org/works/10.1038%2FSJ.CGT.7700361

7 January 2021

Expression of a binding protein for FGF is associated with epithelial development and skin carcinogenesis

1 reference

https://api.crossref.org/works/10.1038%2FSJ.CGT.7700361

7 January 2021

Endothelial cell-derived basic fibroblast growth factor: synthesis and deposition into subendothelial extracellular matrix

1 reference

https://api.crossref.org/works/10.1038%2FSJ.CGT.7700361

7 January 2021

Fibroblast growth factor in the extracellular matrix of dystrophic (mdx) mouse muscle

1 reference

https://api.crossref.org/works/10.1038%2FSJ.CGT.7700361

7 January 2021

Fibroblast growth factors are present in the extracellular matrix produced by endothelial cells invitro: Implications for a role of heparinase-like enzymes in the neovascular response

1 reference

https://api.crossref.org/works/10.1038%2FSJ.CGT.7700361

7 January 2021

Basic fibroblast growth factor binds to subendothelial extracellular matrix and is released by heparitinase and heparin-like molecules

1 reference

https://api.crossref.org/works/10.1038%2FSJ.CGT.7700361

7 January 2021

Tissue distribution and retinoid-mediated downregulation of an FGF-binding protein (FGF-BP) in the rat

1 reference

https://api.crossref.org/works/10.1038%2FSJ.CGT.7700361

7 January 2021

Structural characterization of the fibroblast growth factor-binding protein purified from bovine prepartum mammary gland secretion.

1 reference

https://api.crossref.org/works/10.1038%2FSJ.CGT.7700361

7 January 2021

p53 mediated sensitization of squamous cell carcinoma of the head and neck to radiotherapy

1 reference

https://api.crossref.org/works/10.1038%2FSJ.CGT.7700361

7 January 2021

Inhibition of the growth of pre-established subcutaneous tumor nodules of human prostate cancer cells by single injection of the recombinant adenovirus p53 expression vector

1 reference

https://api.crossref.org/works/10.1038%2FSJ.CGT.7700361

7 January 2021

Effect of herpes simplex virus thymidine kinase expression levels on ganciclovir-mediated cytotoxicity and the "bystander effect".

1 reference

https://api.crossref.org/works/10.1038%2FSJ.CGT.7700361

7 January 2021

Gene therapy of hepatoma: bystander effects and non-apoptotic cell death induced by thymidine kinase and ganciclovir

1 reference

https://api.crossref.org/works/10.1038%2FSJ.CGT.7700361

7 January 2021

The extent of heterocellular communication mediated by gap junctions is predictive of bystander tumor cytotoxicity in vitro

1 reference

https://api.crossref.org/works/10.1038%2FSJ.CGT.7700361

7 January 2021

The role of immunosuppression in the efficacy of cancer gene therapy using adenovirus transfer of the herpes simplex thymidine kinase gene.

1 reference

https://api.crossref.org/works/10.1038%2FSJ.CGT.7700361

7 January 2021

In vitro evidence that metabolic cooperation is responsible for the bystander effect observed with HSV tk retroviral gene therapy

1 reference

https://api.crossref.org/works/10.1038%2FSJ.CGT.7700361

7 January 2021

Gene therapy of cancer

1 reference

https://api.crossref.org/works/10.1038%2FSJ.CGT.7700361

7 January 2021

Regression of established macroscopic liver metastases after in situ transduction of a suicide gene

1 reference

https://api.crossref.org/works/10.1038%2FSJ.CGT.7700361

7 January 2021

Contribution of CD95 ligand-induced neutrophil infiltration to the bystander effect in p53 gene therapy for human cancer

1 reference

https://api.crossref.org/works/10.1038%2FSJ.CGT.7700361

7 January 2021

Parenteral gene therapy with p53 inhibits human breast tumors in vivo through a bystander mechanism without evidence of toxicity

1 reference

https://api.crossref.org/works/10.1038%2FSJ.CGT.7700361

7 January 2021

Radioresistant tumor cells are present in head and neck carcinomas that recur after radiotherapy

1 reference

https://api.crossref.org/works/10.1038%2FSJ.CGT.7700361

7 January 2021

Adenovirus mediated expression of therapeutic plasma levels of human factor IX in mice

1 reference

https://api.crossref.org/works/10.1038%2FSJ.CGT.7700361

7 January 2021

Evaluation of the efficacy and safety of in vitro, adenovirus-mediated transfer of the human cystic fibrosis transmembrane conductance regulator cDNA.

1 reference

https://api.crossref.org/works/10.1038%2FSJ.CGT.7700361

7 January 2021

Induction of the growth inhibitor IGF-binding protein 3 by p53

1 reference

https://api.crossref.org/works/10.1038%2FSJ.CGT.7700361

7 January 2021

The tumor suppressor p53 regulates its own transcription

1 reference

https://api.crossref.org/works/10.1038%2FSJ.CGT.7700361

7 January 2021

Control of angiogenesis in fibroblasts by p53 regulation of thrombospondin-1

1 reference

https://api.crossref.org/works/10.1038%2FSJ.CGT.7700361

7 January 2021

How tumors become angiogenic

1 reference

https://api.crossref.org/works/10.1038%2FSJ.CGT.7700361

7 January 2021

Sequential development of an angiogenic phenotype by human fibroblasts progressing to tumorigenicity

1 reference

https://api.crossref.org/works/10.1038%2FSJ.CGT.7700361

7 January 2021

Systemic gene delivery expands the repertoire of effective antiangiogenic agents

1 reference

https://api.crossref.org/works/10.1038%2FSJ.CGT.7700361

7 January 2021

Elevated levels of an angiogenic peptide, basic fibroblast growth factor, in the urine of patients with a wide spectrum of cancers

1 reference

https://api.crossref.org/works/10.1038%2FSJ.CGT.7700361

7 January 2021

A secreted FGF-binding protein can serve as the angiogenic switch in human cancer.

1 reference

https://api.crossref.org/works/10.1038%2FSJ.CGT.7700361

7 January 2021

Induction of the angiogenic modulator fibroblast growth factor-binding protein by epidermal growth factor is mediated through both MEK/ERK and p38 signal transduction pathways.

1 reference

https://api.crossref.org/works/10.1038%2FSJ.CGT.7700361

7 January 2021

Phorbol ester-induced transcription of a fibroblast growth factor-binding protein is modulated by a complex interplay of positive and negative regulatory promoter elements.

1 reference

https://api.crossref.org/works/10.1038%2FSJ.CGT.7700361

7 January 2021

Insulin-like growth factor (IGF)-binding protein-3 induces apoptosis and mediates the effects of transforming growth factor-beta1 on programmed cell death through a p53- and IGF-independent mechanism

1 reference

https://api.crossref.org/works/10.1038%2FSJ.CGT.7700361

7 January 2021

Peptides derived from two separate domains of the matrix protein thrombospondin-1 have anti-angiogenic activity

1 reference

https://api.crossref.org/works/10.1038%2FSJ.CGT.7700361

7 January 2021

Insulin-like growth factor binding protein 3 (IGFBP-3): a novel target of the tumor suppressor p53 inhibiting cell growth

1 reference

https://api.crossref.org/works/10.1038%2FSJ.CGT.7700361

7 January 2021

The evaluation of adenoviral p53-mediated bystander effect in gene therapy of cancer

1 reference

https://api.crossref.org/works/10.1038%2FSJ.CGT.7700361

7 January 2021

Adenovirus-mediated p53 gene transfer in advanced non-small-cell lung cancer

1 reference

https://api.crossref.org/works/10.1038%2FSJ.CGT.7700361

7 January 2021

Novel combination therapy for human colon cancer with adenovirus-mediated wild-type p53 gene transfer and DNA-damaging chemotherapeutic agent

1 reference

https://api.crossref.org/works/10.1038%2FSJ.CGT.7700361

7 January 2021

Adenovirus-mediated p53 gene transfer in patients with advanced recurrent head and neck squamous cell carcinoma

1 reference

https://api.crossref.org/works/10.1038%2FSJ.CGT.7700361

7 January 2021

Identifiers

DOI

10.1038/SJ.CGT.7700361

1 reference

1 September 2017

1 reference